PLUTO Portfolio Dashboard

A calm summary of modeled exposure, residual risk, active validation, and treatment execution.

admin@pluto.local
Use the left navigation to move through the PLUTO lifecycle: cases, scenarios, assumptions, business input, analysis, risk items, treatment plans, objectives, work items, and evidence.
Modeled Exposure Total estimated annual loss before treatment across modeled risk items.⌄ How calculatedSum of Expected Annual Loss across risk items in the current scope. $7.2M Across healthcare scenarios
Residual Exposure Estimated annual loss remaining after treatment effects are applied.⌄ How calculatedSum of Residual Expected Loss after treatment effects are applied. $3.9M After active treatment plans
Planned Reduction Expected reduction from objectives in flight or planned.⌄ How calculatedSum of Expected Risk Reduction across planned and active objectives. $2.4M Objectives in flight
Completed Reduction Expected reduction from completed objectives with supporting status or evidence.⌄ How calculatedSum of Expected Risk Reduction for completed objectives. $910K Evidence-backed this quarter

Top Healthcare Risk Items

Finalized and in-progress scenarios sorted by exposure, maturity, and treatment status.

Risk Item Exposure Confidence Owner Maturity
EHR downtime from ransomware disrupts clinical operations
Case: EHR downtime review
$4.6M High Clinical Ops Level 3
PHI exposure from account compromise triggers breach response
Case: Identity and PHI exposure review
$1.8M Medium Privacy Office Input Requested
Medical device segmentation gap creates operational risk
Case: Clinical engineering network review
$820K Low Clinical Engineering Level 1
Third-party billing vendor breach delays revenue operations
Case: Vendor incident exposure review
$1.2M Medium Revenue Cycle Level 2

Business Input and Work Status

Open validation requests and treatment objectives that need attention.

Validate EHR downtime duration assumption Requested from: Clinical Operations - due May 17
Sent
Complete quarterly restore test for Tier 1 clinical systems Owner: Infrastructure - evidence required
$780K/yr
Document manual downtime workflow coverage by department Owner: Emergency Management - due May 31
$410K/yr

Executive Reports

Leadership-ready outputs generated from validated scenarios and active treatment work.

EHR downtime executive risk summary

Shows exposure, confidence, treatment decision, required evidence, and residual risk.

Level 3$2.1M residual
Third-party billing vendor exposure brief

Shows vendor breach exposure, revenue impact assumptions, treatment path, and evidence gaps.

Level 2$1.2M modeled
PLUTO Executive Risk Summary

EHR downtime review

A ransomware event prevents reliable access to the EHR, forcing manual downtime procedures and delaying clinical operations.

Expected Annual Loss Estimated annualized loss before treatment.⌄ How calculatedEvent frequency x success probability x loss magnitude.$4.6M
Residual Expected Loss Estimated annualized loss after treatment.⌄ How calculatedExpected Annual Loss reduced by modeled treatment effect.$2.1M
P95 Loss High-end modeled loss estimate.⌄ How calculatedThe 95th percentile of modeled loss outcomes.$8.9M
Completed Reduction Expected reduction from completed linked objectives.⌄ How calculatedSum of expected reduction for linked objectives marked complete.$910K

Scenario and Impact

Threat event: ransomware disrupts access to core clinical systems.

Affected process: patient care coordination, emergency department intake, inpatient documentation, and recovery operations.

Control weakness: restore testing and downtime workflow validation are not yet consistent across critical departments.

Treatment Position

Decision: Mitigate.

Rationale: reduce downtime duration and recovery uncertainty through restore testing, downtime workflow signoff, and monitoring improvements.

Key Assumptions

Clinical downtime duration - Medium confidence, validation requested from Clinical Operations.

Recovery labor cost - High confidence, validated by Infrastructure.

Manual workflow coverage - Medium confidence, evidence still required.

Work Status

1 completed objective.

2 active objectives.

1 blocked objective awaiting business validation.

3 work items tracked.

Evidence Summary

2 evidence items collected.

Restore test summary reviewed; downtime workflow signoff packet submitted.

Decision / Ask

Approve the treatment path, assign owners for outstanding validation, and require evidence before residual risk is recalculated.

PLUTO Executive Risk Summary

Third-party billing vendor exposure brief

A billing operations vendor experiences a security incident that interrupts claims processing, delays revenue workflows, and creates privacy review obligations.

Expected Annual Loss Estimated annualized loss before treatment.⌄ How calculatedEvent frequency x success probability x loss magnitude.$1.2M
Residual Expected Loss Estimated annualized loss after treatment.⌄ How calculatedExpected Annual Loss reduced by modeled treatment effect.$720K
P95 Loss High-end modeled loss estimate.⌄ How calculatedThe 95th percentile of modeled loss outcomes.$3.4M
Completed Reduction Expected reduction from completed linked objectives.⌄ How calculatedSum of expected reduction for linked objectives marked complete.$180K

Scenario and Impact

Threat event: third-party vendor breach or outage impacts billing operations.

Affected process: claims submission, payment posting, patient billing support, and privacy review.

Control weakness: vendor incident response expectations, evidence requirements, and alternate processing workflows are not fully validated.

Treatment Position

Decision: Mitigate.

Rationale: reduce revenue interruption and response uncertainty through vendor SLA validation, alternate workflow testing, and evidence-backed tabletop review.

Key Assumptions

Claims processing interruption - Medium confidence, validation requested from Revenue Operations.

Vendor notification timing - Low confidence, contract evidence still required.

Privacy review effort - Medium confidence, estimate provided by Privacy Office.

Work Status

0 completed objectives.

3 active objectives.

1 blocked objective awaiting vendor documentation.

4 work items tracked.

Evidence Summary

1 evidence item collected.

Vendor contact matrix submitted; contract SLA and alternate workflow test evidence still required.

Decision / Ask

Approve vendor response validation, assign revenue operations owner, and require SLA evidence before moving this brief to executive-ready status.

Active Objectives Objectives not yet marked complete across active treatment plans.⌄ How calculatedCount of linked objectives with status other than Complete.9Across treatment plans
Blocked Work Work items that need evidence, owner input, or dependency resolution.⌄ How calculatedCount of work items with Blocked status.2Evidence or owner needed
Due This Month Priority work items with due dates in the current month.⌄ How calculatedCount of open work items due within this calendar month.5Priority work items

Work Queue

Risk-derived work items with owners, expected reduction, and status.

Complete restore test for Tier 1 clinical systems

Owner: Infrastructure. Evidence: restore report and screenshots.

Active$780K/yr
Validate downtime workflow coverage by department

Owner: Emergency Management. Linked to EHR downtime scenario.

In Review$410K/yr
Confirm vendor incident communication SLA

Owner: Vendor Management. Evidence still required.

Blocked$260K/yr

Cases

Parent workspaces for investigations, business concerns, and risk programs.

EHR downtime review

Business owner: Clinical Operations. Security owner: Infrastructure Security.

HighActive
Identity and PHI exposure review

Business owner: Privacy Office. Security owner: IAM.

MediumReview
Vendor incident exposure review

Business owner: Revenue Cycle. Security owner: Third Party Risk.

HighActive

Scenarios

Drafts ready for assumptions, business validation, and analysis.

Ransomware disrupts EHR access

Clinical downtime, recovery effort, delayed care coordination, and response cost.

Level 3$4.6M
Compromised account exposes PHI

Investigation cost, notification obligations, legal review, and operational disruption.

Input Requested$1.8M

Assumptions

Inputs, ranges, sources, confidence, and validation state behind every modeled output.

AssumptionRangeSourceConfidenceValidation
Time impact estimate
Time Impact
8-36 hoursClinical Ops validationMediumRequested
Loss magnitude estimate
Loss Magnitude
$120K-$440KFinance validationHighValidated
Frequency estimate
Frequency
0.1-0.4 events/yearSecurity and ops inputMediumNeeds Validation

Business Input Requests

Targeted validation requests for stakeholders who know the impact details.

Validate clinical downtime duration

Recipient role: Clinical Operations. Due May 17.

Sent
Confirm revenue cycle interruption cost

Recipient role: Revenue Operations. Due May 20.

Draft

Scenario Analysis

Save or update the scenario's modeled exposure, residual loss, and treatment value.

Risk Items

Finalized modeled risks with treatment decision, confidence, and residual exposure.

EHR downtime from ransomware

Treatment decision: Mitigate. Confidence: High.

$4.6MActive
PHI exposure from account compromise

Treatment decision: Mitigate. Confidence: Medium.

$1.8MReview

Treatment Plans

Approved responses with rationale, cost, expected reduction, and owner.

Improve clinical-system recovery assurance

Strategy: Mitigate. Rationale: reduce downtime duration and recovery uncertainty.

$1.9M expected reductionApproved
Tighten privileged access monitoring

Strategy: Mitigate. Rationale: lower likelihood of PHI exposure through account misuse.

$640K expected reductionDraft

Objectives

Risk-reduction outcomes with owners, due dates, effort, confidence, and evidence needs.

Complete restore test for Tier 1 clinical systemsOwner: Infrastructure - due May 24
$780K/yr
Validate downtime workflow coverage by departmentOwner: Emergency Management - due May 31
$410K/yr

Work Items

Assigned security work derived from approved objectives and risk-reduction theses.

Run restore test in non-production recovery environment

Assignee: Infrastructure Analyst. Due May 21.

Active
Collect department downtime signoff artifacts

Assignee: Emergency Management Coordinator. Due May 28.

In Progress
Update escalation checklist for clinical-system outage

Assignee: Incident Response Lead. Due June 4.

Not Started

Evidence

Artifacts that prove completion and support residual risk recalculation.

Restore test summary

Linked to restore testing objective. Status: reviewed.

Reviewed
Downtime workflow signoff packet

Linked to departmental workflow validation. Status: submitted.

Submitted
Privileged access alert tuning evidence

Linked to account compromise treatment plan. Status: requested.

Requested